Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Development and Usability Testing of the Society for Pediatric Anesthesia Pedi Crisis Mobile Application.
Principal Investigator
Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing.
Nuclear factor-?B in glioblastoma: insights into regulators and targeted therapy.
Hydrogenase activity and photoassimilation.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Navari, Rudolph
One or more keywords matched the following items that are connected to
Navari, Rudolph
Item Type
Name
Concept
Serotonin 5-HT3 Receptor Antagonists
Academic Article
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
Academic Article
Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Academic Article
Emerging drugs for chemotherapy-induced emesis.
Academic Article
Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.
Academic Article
Prevention of emesis from multiple-day and high-dose chemotherapy regimens.
Academic Article
Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist.
Academic Article
Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.
Academic Article
New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations.
Academic Article
Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.
Academic Article
Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.
Academic Article
5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Academic Article
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
Academic Article
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.
Academic Article
Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.
Academic Article
Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.
Academic Article
Do we still need to study palonosetron for chemotherapy-induced nausea and vomiting? A cumulative meta-analysis.
Search Criteria
Serotonin 5 HT3 Receptor Antagonists